Tag: Exclusive

Progesterone Test Wands to Maximize the Chances of Conception: Interview with Sylvia Kang, CEO of Mira

Mira is a medical device company based in California specializing in technology that helps women maximize their chances of conception and monitor their reproductive health. Fertility problems are on the rise, with sperm counts dropping and many couples having difficulties conceiving. Technology can assist in maximizing the potential of conception b (Read more...)

Catheter-Deliverable Biomaterial Sealants: Interview with Natalie Artzi, Co-founder of BioDevek

BioDevek, a medtech company based in Cambridge, Massachusetts, has developed a biomaterial adhesive that acts to seal internal wounds and incisions. The material is designed to be sprayed through a catheter, and the primary application for the technology so far is to act as a sealant following colonic polyp resection. At present, following polyp re (Read more...)

Cold Cap Therapy for Chemo Patients: Interview with Kate Dilligan, CEO of Cooler Heads Care

Cooler Heads Care, a medtech company based in San Diego, created Amma, a cold cap therapy device that aims to help chemotherapy patients to preserve their hair. Hair loss is a very common side-effect of chemo, and poses a significant psychological challenge for patients who are already struggling with their diagnosis and treatment. Simply cooling [ (Read more...)

Wireless Blood Pressure and Hemodynamic Monitoring: Interview with Jeff Pompeo, CEO, Caretaker Medical

Caretaker Medical, a company based in Virginia, developed the VitalStream wireless patient monitor, and the company recently announced that the device has received FDA clearance. The technology is intended to improve on traditional blood pressure cuffs that provide only a snap-shot of blood pressure data, while being an alternative, in many cases, (Read more...)

Medgadget Reviews the Sleep Number i10 360 Smart Bed

Ten years ago, Sleep Number gave Medgadget the opportunity to try out their advanced beds. As you’ve probably seen on numerous TV commercials and in retail outlets, Sleep Number beds are known for their adjustable firmness, accomplished by changing the air pressure inside their mattresses. We had enjoyed sleeping on the bed, but found that [& (Read more...)

DNA Aptamers for Rapid COVID-19 Testing: Interview with Steven Goh, CEO of Achiko and Dr. Michael Edel, Inventor of AptameX

Achiko, a company based in Switzerland, has developed AptameX, a saliva-based rapid COVID-19 test. The technology is based on DNA aptamers that are bound to gold nanoparticles. On binding with a viral protein the gold nanoparticles are released, causing a measurable color change. The test takes approximately 15 minutes in total, with the user spend (Read more...)

EvoWalk Digital Therapy Platform: Interview with Pierluigi Mantovani, CEO at Evolution Devices

Evolution Devices, a company based in California, created a functional electrical stimulation device to assist people with foot drop to walk more freely. Foot drop is caused by muscle weakness/paralysis, and those affected struggle to lift the front part of their foot, which makes walking difficult and can lead to falls. The product is called [&hel (Read more...)

Eyevensys Electrotransfection System for Ocular Disease: Interview with Patricia Zilliox, CEO

Eyevensys, a medtech company based in France, has developed the Eyevensys Electrotransfection System, a non-viral transfection system for the treatment of ocular diseases. So far, the firm has demonstrated the safety of the technique in treating noninfectious uveitis and is developing treatments for geographic atrophy, retinitis pigmentosa, and wet (Read more...)

Neuromodulation for Lennox-Gastaut Syndrome: Interview with Martha Morrell, M.D., CMO of NeuroPace

NeuroPace, a medtech company based in California, has developed the RNS system, an implantable neuromodulation device for focal drug-resistant epilepsy. The system continuously monitors brain activity and then responds appropriately to target the seizure source in the brain for personalized seizure prevention. The company reports that the stimulati (Read more...)

Levita Robotic Platform: Interview with Alberto Rodriguez-Navarro, CEO of Levita Magnetics

Levita Magnetics, a California-based company that specializes in laparoscopic systems, has recently announced that its Levita Robotic Platform, a surgical robot that is still in development, has been used to perform surgery on a patient for the first time in a hospital in Chile. The robot uses similar magnetic technology as in the company’s h (Read more...)

Remote Monitoring for Cardiac Patients: Interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity

Biotricity, a medtech company based in California, developed the Bioflux system, a mobile cardiac telemetry device. The system is a three channel ECG monitor, and it enables continuous data collection and data transmission to a call center in the case of anomaly detection. If the detected issue is considered to be serious, a clinician can [… (Read more...)

Remote Monitoring for Peritoneal Dialysis: Interview with Aly ElBadry, CEO of CloudCath

CloudCath, a medtech company based in San Francisco, has created the CloudCath system, a remote monitoring technology that provides clinicians with data on the spent dialysate fluid of at-home peritoneal dialysis patients. CloudCath is incorporated into the drain line of peritoneal dialysis systems, and wirelessly transmits data to the cloud, with (Read more...)

Aortic Occlusion to Enhance Blood Flow to Brain and Heart: Interview with Habib Frost, CEO of Neurescue

Neurescue, a medtech company based in Denmark, created the NEURESCUE system, a balloon catheter designed to occlude the aorta, resulting in a significant increase in blood flow to the heart and brain. The mechanism is intended to provide emergency treatment for patients suffering a hemorrhage or cardiac arrest. Both hemorrhage and cardiac arrest re (Read more...)

Rapid Diagnosis of Infectious Disease at Point of Care: Interview with Shawn Marcel, CEO of Torus Biosystems

Torus Biosystems, a medtech startup that spun out of Harvard’s Wyss Institute for Biologically Inspired Engineering, has developed the Synestia system, a point of care diagnostic tool for infectious disease. The system aims to provide rapid, point-of-care identification of pathogens, and incorporates microarray and qPCR technology.  &nbs (Read more...)